Viridian Therapeutics, Inc. (VRDN)
21.24
-1.05
(-4.71%)
USD |
NASDAQ |
Sep 11, 16:00
20.70
-0.54
(-2.54%)
After-Hours: 20:00
Viridian Therapeutics Price : 21.24 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 22.48 | 22.70 | 21.18 | 21.24 | 944077.0 |
| Sep 10, 2026 | 22.40 | 22.60 | 21.99 | 22.29 | 1.310M |
| Sep 09, 2026 | 23.11 | 23.58 | 22.70 | 22.73 | 1.578M |
| Sep 08, 2026 | 22.38 | 23.84 | 22.22 | 23.17 | 1.829M |
| Sep 04, 2026 | 22.62 | 23.03 | 22.62 | 22.92 | 759916.0 |
| Sep 03, 2026 | 23.08 | 23.28 | 22.57 | 22.96 | 1.194M |
| Sep 02, 2026 | 23.11 | 23.74 | 22.39 | 22.78 | 1.417M |
| Sep 01, 2026 | 23.02 | 23.34 | 22.88 | 23.03 | 998383.0 |
| Aug 31, 2026 | 22.94 | 23.27 | 22.62 | 23.16 | 1.049M |
| Aug 28, 2026 | 23.58 | 23.70 | 23.04 | 23.08 | 778882.0 |
| Aug 27, 2026 | 24.22 | 24.47 | 23.75 | 23.88 | 839843.0 |
| Aug 26, 2026 | 24.16 | 24.46 | 23.92 | 24.26 | 780820.0 |
| Aug 25, 2026 | 24.30 | 24.80 | 24.08 | 24.18 | 901427.0 |
| Aug 24, 2026 | 24.35 | 24.39 | 24.00 | 24.02 | 1.131M |
| Aug 21, 2026 | 24.65 | 24.74 | 24.07 | 24.29 | 906295.0 |
| Aug 20, 2026 | 24.61 | 24.72 | 23.96 | 24.50 | 1.076M |
| Aug 19, 2026 | 24.52 | 24.86 | 23.80 | 24.80 | 1.834M |
| Aug 18, 2026 | 23.00 | 23.95 | 22.84 | 23.93 | 1.993M |
| Aug 17, 2026 | 21.92 | 23.29 | 21.87 | 23.09 | 1.893M |
| Aug 14, 2026 | 22.00 | 22.23 | 21.62 | 22.08 | 1.093M |
| Aug 13, 2026 | 22.70 | 22.86 | 21.89 | 21.99 | 1.768M |
| Aug 12, 2026 | 23.16 | 23.60 | 22.72 | 22.88 | 1.578M |
| Aug 11, 2026 | 23.23 | 23.83 | 22.81 | 22.97 | 3.063M |
| Aug 10, 2026 | 23.46 | 23.57 | 22.78 | 23.06 | 2.269M |
| Aug 07, 2026 | 22.98 | 23.61 | 22.53 | 23.59 | 1.660M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Anika Therapeutics, Inc. | 20.86 |
| Savara, Inc. | 5.30 |
| Vericel Corp. | 38.34 |
Price Related Metrics
| PS Ratio | 28.84 |
| Price to Book Value | 4.264 |
| Earnings Yield | -17.46% |
| Market Cap | 2.405B |